• 제목/요약/키워드: Pelvic RT

검색결과 41건 처리시간 0.037초

The location of locoregional recurrence in pathologic T3N0, non-irradiated lower rectal cancer

  • Kim, Mi Sun;Keum, Ki Chang;Rhee, Woo Joong;Kim, Hyunju;Kim, Minji;Choi, Seohee;Nam, Ki Chang;Koom, Woong Sub
    • Radiation Oncology Journal
    • /
    • 제31권2호
    • /
    • pp.97-103
    • /
    • 2013
  • Purpose: To investigate the patterns of locoregional recurrence of pathologic T3N0 (pT3N0) lower rectal cancer omitting postoperative radiotherapy (RT) and explore the potential of modification of a RT field. Materials and Methods: From Jan 2003 to Nov 2011, 35 patients omitting preoperative or postoperative RT for pT3N0 lower rectal cancer were included. We defined the lower rectal cancer as the tumor with the inferior margin located below the virtual line-a convergent level between rectal wall and levator ani muscle. All patients had radiologic examinations for recurrence evaluation during the follow-up duration. Results: The median follow-up duration was 66.4 months (range, 1.4 to 126.1 months). Eight (22.9%) of the 35 patients had recurrence. Three (8.6%) was local recurrence (LR) only, 3 (8.6%) was distant metastasis (DM) only, and 2 (5.7%) was LR with DM. All LR were located at primary tumor sites. The overall survival rate, LR-free survival rate, and DM-free survival rate at 5 years was 79.8%, 83%, and 87%, respectively. All LR developed from tumors over 5 cm. However, there was no statistical significance (p = 0.065). There was no other risk factor for LR. Conclusion: Even though the patients included in this study had pathologically favorable pT3N0 rectal cancer, LR developed in 14.3% of patients. Most of the LR was located at primary tumor sites prior to surgery. Based on these findings, it might seem reasonable to consider postoperative RT with a smaller radiation field to the primary tumor site rather than the conventional whole pelvic irradiation.

자궁경부암의 수술후 방사선치료 결과 (Therapeutic Results of Postoperative Radiation Therapy for Uterine Cervical Cancer)

  • 최두호;홍성언
    • Radiation Oncology Journal
    • /
    • 제12권3호
    • /
    • pp.369-376
    • /
    • 1994
  • This is a retrospective analysis of 64 patients who was treated with postoperative radiation therapy after radical hysterectomy and bilateral pelvic lymphadenectomy (53 patients) or total abdominal hysterectomy(11 patients) for uterine cervix cancer between May 1980 and September 1991 at the Department of Radiation Oncology, Kyung Hee University Hospital. Most patients were FIGO IB (31 Patients) and IIA (25 patients), and median period of follow-up was 5.1 years. Of these patients,24 received adjuvant whole pelvis irradiation of 6000 cGy and 40 received 5000-5500 cGy whole pelvis irradiation and/or intracavitary radiation (7 Patients). The actuarial overall and relapse free 5 year survival rate were $71.0\%$, $68.3\%$ respectively. The survival rates by stage were $79.1\%$ in stage I, and $61.2\%$ in stage II. Treatment failure was noted in 18 of 64 patients ($28.1\%$), Iocoregional failure in 8 ($12.5\%$), distant metastasis in 8 ($12.5\%$), paraaortic node metastasis in 1 and one patient and concurrent locoregional and distant metastasis. The univariate analysis of prognostic factors affecting to overall survival rate represented lymph node status, the number and site of metastatic lymph node, parametrial invasion, the thichness of cervical wall invasion, and size of cancer mass. Histology, vessel invasion, endometrial extension, hemoglobin level. resection margin status, age, radiation dose were not significant prognostic factors. Complication relating to operation and postoperative radiation were variable according to radiation therapy method: 6000 cGy RT group 8/24($33.3\%$), 5000-5500 cGy+ICR 3/7 ($42.9\%$), 5000-5500 cGy external RT only group 3/33 ($9.1\%$). In conclusion, the results suggest that postoperative radiotherapy is necessary in high risk patients for locoregional control and improving survival rate, and higher dose does not improve results but only increases complication.

  • PDF

Fertility-Preserving Treatments in Patients with Gynecological Cancers: Chinese Experience and Literature Review

  • Liu, Chun-Yan;Li, Hua-Jun;Lin, Hua;Ling, Bin
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권12호
    • /
    • pp.4839-4841
    • /
    • 2015
  • We conducted a retrospectively reviewed of the literature published of patients underwent fertility-preserving treatments for cervical, endometrial and ovarian cancers using the WANFANG database in Chinese. A majority were retrospective studies and case reports. With cervical cancer, radical trachelectomy(RT) in combination with pelvic lymphadenectomy could preserve the fertility of patients with early stage IA1-IB1 cancers, Tumor size ${\leq}2cm$ should be emphasized as the indication of RT in considering of the higher recurrent rate in patients with tumor size >2cm. For endometrial cancers, there is much experience on it. Given accurate pretreatment assessment, hormonal therapy is feasible management option to preserve fertility in young patients with early stage lesions that limited to the endometrium and well differentiated. High dose progestin have been applied, oral medroxyprogesterone acetate (MPA), 250-500mg/day, megestrol acetate 160-480mg/day. Other therapies that have been used in a limited number of cases include GnRH analog, intrauterine devices (IUDS) containing progestogen, usually combination of these therapies. All patients should be followed up by ultrasound and/or MRI evaluation, and endometrial curettage at intervals of 3 months. With ovarian cancer, in China, fertilitypreserving surgery in patients with stage IA (grade G1) of epithelial ovarian tumor and patients with germ cell tumor and borderline ovarian tumor have been successfully performed.

Outcomes of Preoperative Chemoradiotherapy and Combined Chemotherapy with Radiotherapy Without Surgery for Locally Advanced Rectal Cancer

  • Supaadirek, Chunsri;Pesee, Montien;Thamronganantasakul, Komsan;Thalangsri, Pimsiree;Krusun, Srichai;Supakalin, Narudom
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권7호
    • /
    • pp.3511-3514
    • /
    • 2016
  • Purpose: To evaluate the treatment outcomes of patients with locally advanced rectal cancer treated with preoperative concurrent chemoradiotherapy (CCRT) or combined chemotherapy together with radiotherapy (CMT-RT) without surgery. Materials and Methods: A total of 84 patients with locally advanced rectal adenocarcinoma (stage II or III) between January $1^{st}$, 2003 and December $31^{st}$, 2013 were enrolled, 48 treated with preoperative CCRT (Gr.I) and 36 with combined chemotherapy and radiotherapy (CMT-RT) without surgery (Gr.II). The chemotherapeutic agents used concurrent with radiotherapy were either 5-fluorouracil short infusion plus leucovorin and/or capecitabine or 5-fluorouracil infusion alone. All patients received pelvic irradiation. Results: There were 5 patients (10.4%) with a complete pathological response. The 3 year-overall survival rates were 83.2% in Gr.I and 24.8 % in Gr.II (p<0.01). The respective 5 year-overall survival rates were 70.3% and 0% (p<0.01). The 5 year-overall survival rates in Gr.I for patients who received surgery within 56 days after complete CCRT as compared to more than 56 days were 69.5% and 65.1% (p=0.91). Preoperative CCRT used for 12 of 30 patients in Gr.I (40%) with lower rectal cancer demonstrated that in preoperative CCRT a sphincter sparing procedure can be performed. Conclusions: The results of treatment with preoperative CCRT for locally advanced rectal cancer showed comparable rates of overall survival and sphincter sparing procedures as compared to previous studies.

Clinical outcomes in patients treated with radiotherapy after surgery for cervical cancer

  • Yang, Kyungmi;Park, Won;Huh, Seung Jae;Bae, Duk-Soo;Kim, Byoung-Gie;Lee, Jeong-Won
    • Radiation Oncology Journal
    • /
    • 제35권1호
    • /
    • pp.39-47
    • /
    • 2017
  • Purpose: The purpose of this study was to analyze clinical outcomes from cervical cancer and stratify patients into risk groups for prognostic factors for early-stage disease. Materials and Methods: We retrospectively reviewed patients with stage IB or IIA cervical cancer treated with adjuvant radiotherapy (RT) or concurrent chemoradiotherapy (CCRT) following primary surgery at Samsung Medical Center from 2001 to 2011. Adjuvant RT was added for patients with intermediate-risk factors, and adjuvant CCRT was performed on high-risk patients after surgery. Results: We reviewed 247 patients-149 in the high-risk group and 98 in intermediate-risk group. The median follow-up was 62 months. Loco-regional failure (LRF) alone occurred in 7 patients (2.8%), distant metastasis alone in 37 patients (15.0%) and LRF with DM in 4 patients (1.6%). The 5-year disease-free survival (DFS) and overall survival (OS) rates for both groups were 79.7% and 87.6%, respectively. In the high-risk group, the 5-year DFS and OS probabilities were 72.5% and 81.9%, respectively. Histologic type, pathologic tumor size, and the number of pelvic lymph node (PLN) metastasis were significant prognostic factors for DFS and OS. We suggest a scoring system (0-3) using these prognostic factors to predict poor prognosis in high-risk patients. Using this system, patients with higher scores have higher recurrence and lower survival rates. Conclusion: In the high-risk cervical-cancer group who received primary surgery and adjuvant CCRT, non-squamous type, large tumor size and the number of PLN metastasis were significant prognostic factors, and the number of these factors was associated with survival rates.

자궁경부암 강내 방사선조사에 있어서 고 및 저 선량율방법에 의한 선량율 비교 고찰 (Comparison Study of Dose Rate and Physical Parameters in Low and High Dose Rate Intracavitary Radiation Systems for Carcinoma of the Uterne Cervix.)

  • 양칠용
    • 대한방사선치료학회지
    • /
    • 제1권1호
    • /
    • pp.70-78
    • /
    • 1985
  • The intrauterine irradiation is essential to achieve adequate tumor dose to centeral tumor mass in radio therapy for uterine malignancy. The complications of pelvic organ are known to be directly related to radiation dose and physical parameters. The comparison study of currently using 2 systems was undertaken. The simulation films and medical records of 135 patients who was treated with intrauterine irradiation at one of general hospitals in Busan and Seoul between Jan. 1983 and June 1983, were critically analized and physical parameters of low dose rate system and remote controlled high dose rate system were measured. The physical parameters include distances between lateral walls of vaginal fornices, longitudinal and lateral angles of tandem to the body axis, the distance from the external os of uterine cervix to the central axis of ovoids, the radiation dose ratio to rectum and bladder to reference point A. Followings were summary of study results: 1. In distances between lateral walls of vaginal fornices the low dose rate system showed wide distribution and relatively larger distances. In low dose rate system 5.0-5.9 cm was $55.89\%$ 6.0-6.9 cm: $23.53\%$, 4.0-4.9cm: $10.29\%$, 3.0-3.9cm: $10.29\%$, and in high dose rate system 5.0-5.9cm was $80.59\%$, 4.0-4.9cm: $17.91\%$, $6.0\~6.9\;cm:\;1.5\%$. 2. In lateral angulation of tandem to body axis, the low does system revealed mid position (the position along body axis) $64.7\%$, Lt. deviation $19.13\%$ and Rt. deviation $16.17\%$. However the high dose rate system revealed mid position $49.26\%$ Lt. deviation $40.29\%$ and Rt. deviation $10.45\%$. 3. In longitudinal angulation of tandem to body axis the mid position was $11.77\%$ and anterior angulation $88.23\%$ in low dose rate system but in high dose rate system the mid position was $1.56\%$ and anterior angulation $98.44\%$. 4. Down ward displacement of ovoids below external os was only $2.94\%$ in low dose rate system and $67.69\%$ in high dose rate system. 5. The radiation dose ration to rectum to reference point A was $102.70\%$ in high dose rate system and $70.09\%$ in low dose rate system. The dose ratio to bladder to reference point A was $78.14\%$ in high dose rate system and $75.32\%$ in low dose rate system.

  • PDF

세기변조방사선치료에서 Pitch와 Roll 변화에 따른 선량전달 정확성 평가 (Evaluation of dose delivery accuracy due to variation in pitch and roll)

  • 정창영;배선명;이동형;민순기;강태영;백금문
    • 대한방사선치료학회지
    • /
    • 제26권2호
    • /
    • pp.239-245
    • /
    • 2014
  • 목 적 : 세기변조방사선치료에서(Intensity modulated radiation therapy,IMRT) 6D robotic couch의 pitch 와 roll 변화에 따른 선량전달의 정확성을 평가하고자 한다. 대상 및 방법 : Trilogy(Varian Medical Systems, USA)와 6D robotic couch(ProturaTM 1.4, CIVCO, USA)를 사용하여 골반부위의 세기변조방사선치료를 진행한 14명의 환자를 대상으로 영상유도 시 발생한 pitch 와 roll 방향의 오차 값과 발생빈도를 분석하였다. 오차의 변화에 따른 선량전달 정확성의 차이를 평가하기 위해 pitch 와 roll의 변화가 $0^{\circ}$인 상태의 측정치를 기준으로 각각 $1.0^{\circ}$, $1.5^{\circ}$, $2.0^{\circ}$, $2.5^{\circ}$로 변화시킨 경우에 대하여 2차원 이온전리함 배열 검출기(I'mRT Matrixx, IBA Dosimetry,Germany)와 MultiCube Phantom(IBA Dosimetry, Germany)를 이용하여 측정 후 감마지수(3 mm, 3%)의 비교평가를 실시하였다. 실험에는 Dynamic Multi-Leaf Collimator의 sliding window기법을 사용한 3명의 자궁경부암 치료계획을 적용하였다. 결 과 : 대상 환자의 영상(3D/3D Match 78건, 2D/2D match 79건)을 분석한 결과 pitch 와 roll의 평균 오차값은 $0.9^{\circ}{\pm}0.7$, $0.5^{\circ}{\pm}0.6$, 최대 값은 $2.8^{\circ}$, $2.0^{\circ}$로 분석되었고, 최소값은 pitch 와 roll 모두 $0^{\circ}$으로 나타났다. 각각의 조건에서 측정된 선량전달에 대하여 감마지수를 이용하여 비교한 결과, pitch가 $1.0^{\circ}$, $1.5^{\circ}$, $2.0^{\circ}$, $2.5^{\circ}$일 때 gamma pass rate의 평균은 각각 97.75%, 96.65%, 94.38%, 90.91%, roll의 경우 $1.0^{\circ}$, $1.5^{\circ}$, $2.0^{\circ}$, $2.5^{\circ}$에서 평균 93.68%, 93.05%, 87.77%, 84.96%로 나타났고, pitch 와 roll을 동시에 변화시킨 경우 $1.0^{\circ}$, $1.5^{\circ}$, $2.0^{\circ}$에서 평균 94.90%, 92.37%, 87.88%의 결과 값을 얻었다. 결 론 : 대상 환자의 영상 유도 시 pitch 와 roll의 오차 발생률은 전체 치료 횟수에서 각각 82.20%, 72.20%로 분석되었고, 감마지수를 통해 오차 값이 커질수록 선량전달의 정확성이 낮아진다는 것을 확인할 수 있었다. 세기변조방사선치료 시 선량전달의 정확성을 높이기 위해서는 정확한 자세잡이와 더블어 적절한 영상유도를 통해서 pitch 와 roll 방향으로 발생할 수 있는 오차를 줄이도록 노력해야 할 것으로 사료된다.

Association study and expression analysis of olfactomedin like 3 gene related to meat quality, carcass characteristics, retail meat cut, and fatty acid composition in sheep

  • Listyarini, Kasita;Sumantri, Cece;Rahayu, Sri;Uddin, Muhammad Jasim;Gunawan, Asep
    • Animal Bioscience
    • /
    • 제35권10호
    • /
    • pp.1489-1498
    • /
    • 2022
  • Objective: The objective of this study was to identify polymorphism in olfactomedin like 3 (OLFML3) gene, and association analysis with meat quality, carcass characteristics, retail meat cut, and fatty acid composition in sheep, and expression quantification of OLFML3 gene in phenotypically divergent sheep. Methods: A total of 328 rams at the age of 10 to 12 months with an average body weight of 26.13 kg were used. A novel polymorphism was identified using high-throughput sequencing in sheep and genotyping of OLFML3 polymorphism was performed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Among 328 rams, 100 rams representing various sheep genotypes were used for association study and proc general linear model was used to analyse association between genotypes and phenotypic traits. Quantitative real-time polymerase chain reaction (qRT-PCR) was used for the expression analysis of OLFML3 mRNA in phenotypically divergent sheep population. Results: The findings revealed a novel polymorphism in the OLFML3 gene (g.90317673 C>T). The OLFML3 gene revealed three genotypes: CC, CT, and TT. The single nucleotide polymorphism (SNP) was found to be significantly (p<0.05) associated with meat quality traits such as tenderness and cooking loss; carcass characteristics such as carcass length; retail meat cut such as pelvic fat in leg, intramuscular fat in loin and tenderloin, muscle in flank and shank; fatty acids composition such as tridecanoic acid (C13:0), palmitoleic acid (C16:1), heptadecanoic acid (C17:0), ginkgolic acid (C17:1), linolenic acid (C18:3n3), arachidic acid (C20:0), eicosenoic acid (C20:1), arachidonic acid (C20:4n6), heneicosylic acid (C21:0), and nervonic acid (C24:1). The TT genotype was associated with higher level of meat quality, carcass characteristics, retail meat cut, and some fatty acids composition. However, the mRNA expression analysis was not different among genotypes. Conclusion: The OLFML3 gene could be a potential putative candidate for selecting higher quality sheep meat, carcass characteristics, retail meat cuts, and fatty acid composition in sheep.

토모테라피와 선형가속기를 이용한 동일 부위의 치료 시 종양 및 정상조직의 흡수선량 평가 (Incase of Same Region Treatment by using a Tomotherapy and a Linear Accelerator Absorbed Dose Evaluation of Normal Tissues and a Tumor)

  • 천금성;김창욱;김회남;허경훈;송진호;홍주영;정재용
    • 대한방사선치료학회지
    • /
    • 제22권2호
    • /
    • pp.97-103
    • /
    • 2010
  • 목 적: 상이한 치료장비를 이용하여 동일 부위에 중복하여 방사선치료 시 전산화치료계획장치간에 호환이 되지 않아 정상조직(Normal Tissue)의 총 흡수선량에 대한 평가의 한계점이 있다. 본 연구에서는 토모테라피(Tomotherapy)와 선형가속기(Linear accelerator)를 이용하여 동일 부위를 중복 치료할 때 환자가 받는 선량을 평가하고자 한다. 대상 및 방법: 인체모형팬텀(Anthropomorphic Phantom)을 대상으로 종양 및 정상조직을 묘사하여 선형가속기 치료계획장치 (Pinnacle 8.0: RTP)로 종양에 45 Gy 선량을 처방하고, 토모테라피 치료계획장치에서 종양에 15 Gy 선량을 처방하여 치료계획을 수립하였다. 토모테라피에서 수립된 치료계획을 통합가능 치료계획장치(Oncentra: RTP)에 전송한 후 동일한 조건으로 토모테라피 치료계획을 재현한 후 선형가속기에서 치료한 45 Gy를 합하여 총 선량 60 Gy의 치료계획을 구현하였다. 흡수선량 평가를 위해 두 개의 방사선 치료계획장치에서 얻어진 흡수선량(최소, 최대, 평균 선량) 및 관심 선량체적에 대해 서로 합(Total)한 값과 하나로 통합(Integration)하여 얻어진 값을 비교 분석하였다. 이를 바탕으로 본원에서 치료받은 환자 중 선형가속기와 토모테라피로 동일 부위에 치료 받은 5명(두경부 2명, 복부 1명, 골반부 2명)에 대하여 동일한 방법으로 종양 및 정상 조직의 흡수선량을 비교 분석하였다. 결 과: 인체모형팬텀에서 하나로 통합하여 얻어진 값과 서로 합한 값의 비교에서 최소선량은 비장(Spleen, 12.4%), 최대선량은 소장(Small bowl, 10.2%)과 척수(Spinal cord, 5.8%)에서 큰 차이를 나타냈다. 두경부 환자의 경우 최소선량은 구강(Oral cavity, 20.3%), 오른쪽 수정체(Rt lens, 7.7%)에서 큰 차이를 나타냈으며, 최대선량은 척수(22.5%), 뇌간(Brain stem; 12.0%), 시 신경교차(Optic chiasm; 8.9%), 오른쪽 수정체(11.5%), 하악골(Mandible bone, 8.1%), 뇌하수체(Pituitary gland, 6.2%)에서 뚜렷한 차이가 나타났다. 복부 환자의 경우 최대선량은 왼쪽 신장(Lt kidney, 20.3%), 위(Stomach, 8.1%)에서 큰 차이가 나타났고, 골반 부위 환자의 경우 최소 선량은 방광(Bladder, 15.2%), 최대선량은 소장(5.6%), 방광(5.5%)에서 큰 차이를 나타냈다. 또한 동일 부위 방사선치료계획 시 정량화되지 못했던 신장의 20 Gy를 받은 체적($V_{20}$)에서 37%, 간(Liver)의 25 Gy를 받은 체적($V_{25}$)에서 23%가 선량체적히스토그램(DVH)에서 나타났다. 결 론: 하나로 통합하여 얻어진 값과 서로 합한 값의 비교에서 최소선량은 높게, 최대선량은 낮게, 평균선량은 동일한 값으로 나타났다. 또한 관심장기의 선량 체적($V_{20}$)보다 낮은 선량을 처방했을 때 구현하지 못했던 종양 및 정상조직의 흡수선량에 대하여 평가를 할 수 있었다. 향후 상이한 치료 장치들을 이용한 동일 부위 치료 시 흡수선량의 통합 평가뿐만 아닌 정확한 선량분포를 구현할 수 있는 치료계획장치의 개발이 요구되어지며, 이에 관련된 연구가 진행되어져야 한다.

  • PDF

자궁경부암 병기 IIB에서의 방사선 치료 성적: 생존율 및 예후인자, 치료 후 실패양상, 만성 합병증 (Radiotherapy Results of Uterine Cervix Cancer Stape IIB : Overall Survival, Prognostic factors, Patterns of Failure and Late Complications)

  • 김은석;최두호;허승재
    • Radiation Oncology Journal
    • /
    • 제16권1호
    • /
    • pp.51-61
    • /
    • 1998
  • 목적 : 2기말 이상의 진행된 병기의 자궁경부암은 근치적 수술이 불가능하거나 수술시 높은 국소 재발율을 보이기 때문에 방사선 치료가 주된 치료 방법으로 사용되며, 5년 생존율은 $60-65\%$정도 보고되고 있다. 이에 근치적 방사선 치료를 시행한 2기말 자궁경부암 환자의 생존율과 치료의 반응, 실패율, 부작용 등을 비교하기 위해 후향적 분석을 시행하였다. 대상 및 방법 1985년 8월부터 1994년 8월까지 순천향대학병원과 외부 병원에서 외부 전골반 방사선 치료를 시행후 순천향대학병원에서 고선량률 강내치료를 근치적 목적으로 시행하여 치료를 완료한 원발 자궁경부암 2기말 198명의 환자 중 추적 관찰이 가능했던 167명의 환자를 대상으로 분석하였다. 환자의 추적 관찰 기간은 3개월부터 141개월(평균 60개월)이였으며 최소 추적기간은 30개월이었고, 연령은 31세부터 78세(평균 연령은 55세)였다. 통계학적인 분석에서 생존율과 생존 곡선은 Kaplan-Meter 방법을 사용하였고 각 군의 비교는 log-rank test를 이용하였고 다변량 분석은 Cox-regression 방법을 사용하였다. 재발이나 합병증에 대한 영향은 chi-square와 두 가지 이상의 경우에는 linear trend 분석을 이용하였다. 결과 : 치료에 대한 반응은 모든 환자의 $84\%$에서 완전관해율을 보였고, 병리 조직학적으로 편평상피암에서 $86\%$의 완전 관해를 보인 반면 선암에서는 $60\%$의 완전관해율을 보였으며 통계학적 유의성이 있었다. 5년 생존율과 5년 무병 생존율은 각각 $62\%$$59\%$ 였고 예후 인자는 병소의 크기와 치료에 대한 반응이었으며, 병리학적 종류와 자궁 주변 침범의 정도는 경계의 의미가 있었다. 57명의 치료 실패가 있었으며 국소 재발은 2년 이내가 대부분 이었고 원격 전이는 3년 이후도 $29\%$를 보였다. 만성 합병증은 28명(16.8%) 38건에서 보였으며 발생률과 심한 정도가 총 선량과 1회당 선량에 유의한 상관관계가 있었다. 결론 : 국소적으로 진행된 자궁경부암은 종양의 크기와 치료에 대한 반응이 생존율과 국소재발에 가장 영향을 주는 요소이므로 방사선 치료를 할 때 종양의 크기에 따라 세분화하고 종양이 큰 경우 기존의 방법으로는 실패율이 비교적 높으므로 방사선 치료 기간의 단축이나 항암제의 추가 등을 고려하여 치료의 효과를 높여야 하며, 환자의 추적 관찰은 2년 이내 국소재발과 원격 전이가 많으므로 2년 이내는 적극적 추적 관찰의 중요성과 원격 전이의 경우 3년 이후 5년 이내에도 재발이 많기 때문에 종양표지자나 방사선학적 추적 관찰이 중요하다. 그리고 만성 합병증을 최소화하기 위해 적절한 질 packing 등으로 주위 조직의 방사선 피폭량을 줄여야 할 것으로 생각된다.

  • PDF